- Current report filing (8-K)
21 Dezembro 2012 - 9:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 21, 2012 (December 18, 2012)
INKSURE TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
DELAWARE
|
000-24431
|
84-1417774
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
589 Fifth Avenue, Suite 401, New York, NY
|
10017
|
(Address of principal executive offices)
|
(Zip Code)
|
(646) 233-1454
---------------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
At the Annual Meeting, the Company elected five directors, each for a one-year term of office to serve until the Company's 2013 Annual Meeting of stockholders, or until his successor is elected and qualified. The nominated directors received the following votes:
DIRECTOR
|
FOR
|
WITHHOLD
|
Gadi Peleg
|
23,358,636
|
48,100
|
Jonathan Bettsack
|
23,286,783
|
119,953
|
Alon Raich
|
23,358,636
|
48,100
|
David W. Sass
|
23,358,636
|
48,100
|
Pierre Schoenheimer
|
23,327,636
|
79,100
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INKSURE TECHNOLOGIES, INC.
Date: December 21, 2012
By: /s/ Tal Gilat
-----------------
Name: Tal Gilat
Title: President and Chief Executive Officer
Artemis Therapeutics (PK) (USOTC:ATMS)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Artemis Therapeutics (PK) (USOTC:ATMS)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Artemis Therapeutics Inc (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de